Back
Anavex Life Sciences Corp. 10K Form
Sell
26
AVXL
Anavex Life Sciences Corp.
Last Price:
$4.45
Seasonality Move:
3.46%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-08-08 | 10Q | AVXL/Anavex Life Sciences Corp. Quarterly |
| 2023-05-09 | 10Q | AVXL/Anavex Life Sciences Corp. Quarterly |
| 2023-02-07 | 10Q | AVXL/Anavex Life Sciences Corp. Quarterly |
| 2022-08-09 | 10Q | AVXL/Anavex Life Sciences Corp. Quarterly |
| 2022-05-10 | 10Q | AVXL/Anavex Life Sciences Corp. Quarterly |
| 2022-02-09 | 10Q | AVXL/Anavex Life Sciences Corp. Quarterly |
Receive AVXL News And Ratings
See the #1 stock for the next 7 days that we like better than AVXL
AVXL Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-8.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.09 |
| Price / Book: | 4.19 |
Profitability
| EPS (TTM): | -0.54390 |
|---|---|
| Net Income (TTM): | $-46.4M |
| Gross Margin: | $0 |
| Return on Equity: | -44.87% |
| Return on Assets: | -39.77% |
Anavex Life Sciences Corp. Earnings Forecast
Key Anavex Life Sciences Corp. Financial Ratios
-
Per Share Earnings over the last 22 years have been positive in 9 years.
Anavex Life Sciences Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AVXL |
| CUSIP: | 032797 |
| Website: | anavex.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 11.6 |
| Quick Ratio: | 11.47 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 3.5 |
AVXL Technical Analysis vs Fundamental Analysis
Sell
26
Anavex Life Sciences Corp. (AVXL)
is a Sell
Is Anavex Life Sciences Corp. a Buy or a Sell?
-
Anavex Life Sciences Corp. stock is rated a SellThe current Anavex Life Sciences Corp. [AVXL] share price is $4.45. The Score for AVXL is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.